share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  11/21 05:33

Moomoo AI 已提取核心訊息

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,於2024年11月18日完成了購買299,238股普通股的交易。該交易以每股0.0919美元的價格進行,總投資約爲27,489美元。此次收購是直接進行的,使Chiavacci在該公司的總持股增至351,510股。這筆交易反映了Chiavacci的重大買入,表明他對Conduit Pharmaceuticals未來的信懇智能。
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,於2024年11月18日完成了購買299,238股普通股的交易。該交易以每股0.0919美元的價格進行,總投資約爲27,489美元。此次收購是直接進行的,使Chiavacci在該公司的總持股增至351,510股。這筆交易反映了Chiavacci的重大買入,表明他對Conduit Pharmaceuticals未來的信懇智能。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息